Merck agreed to pay 201 million to resolve multistate litigation alleging that it marketed its drug Vioxx for uses not approved by the United States Food and Drug Administration and misrepresented the cardiovascular safety of the drug, causing false claims to be submitted to state Medicaid programs. This was part of a larger 950 million civil and criminal settlement involving the federal government; ###-merck-sharp-and-dohme